Mid-Term Efficacy of Dupilumab in Children Aged≥36 Months to <12 Years With Atopic Dermatitis: A Case Series

Actas Dermosifiliogr. 2024 Feb 17:S0001-7310(24)00138-8. doi: 10.1016/j.ad.2023.04.042. Online ahead of print.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports